We are live on ! Find out more
INGN icon

Inogen

237 hedge funds and large institutions have $3.92B invested in Inogen in 2018 Q2 according to their latest regulatory filings, with 36 funds opening new positions, 75 increasing their positions, 95 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 24 (+2)

51% more capital invested

Capital invested by funds: $2.59B → $3.92B (+$1.33B)

44% more first-time investments, than exits

New positions opened: 36 | Existing positions closed: 25

4% more funds holding

Funds holding: 228237 (+9)

0.17% less ownership

Funds ownership: 99.36%99.19% (-0.17%)

21% less repeat investments, than reductions

Existing positions increased: 75 | Existing positions reduced: 95

22% less call options, than puts

Call options by funds: $20.9M | Put options by funds: $26.7M

Holders
237
Holders Change
+9
Holders Change %
+3.95%
% of All Funds
5.43%
Holding in Top 10
4
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+100%
% of All Funds
0.09%
New
36
Increased
75
Reduced
95
Closed
25
Calls
$20.9M
Puts
$26.7M
Net Calls
-$5.78M
Net Calls Change
-$1.19M

INGN Hedge Fund Activity: Q2 2018 in Review

237 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Inogen (INGN) for Q2 2018, worth a combined $3.92B — up 51% from $2.59B a quarter earlier.

Buyers outnumbered sellers: 36 funds opened new INGN positions and 25 closed out — a net gain of 11 holders — while 75 added to existing stakes and 95 trimmed.

The largest buyer was AllianceBernstein, adding an estimated $39.4M. The largest seller was Fidelity Investments, cutting an estimated $43.9M.

  • 237 institutional investors held Inogen (INGN) as of Q2 2018, up from 228 in Q1 2018.
  • Funds reported $3.92B of Inogen stock for Q2 2018, up 51% quarter-over-quarter.
  • 36 funds opened new Inogen positions in Q2 2018 and 25 closed out, a net change of +11 holders.
  • The largest Inogen buyer in Q2 2018 was AllianceBernstein, an estimated $39.4M added.
  • The largest Inogen seller in Q2 2018 was Fidelity Investments, an estimated $43.9M sold.

Based on aggregated 13F filings for Q2 2018.